The 2nd Kyoto Symposium on the Future of Pharmaceuticals was held at Kyoto University on October 30, 2010. Over 100 researchers and students listened to presentations by FIRST researchers from Shimadzu and Kyoto University. The symposium was intended to introduce the summary of the FIRST research program and its objective to develop the next-generation mass spectrometer through industry-university cooperation, and contribute to drug discovery and new diagルーレット ルールstic methods. A lively discussion followed each presentation by a researcher.
|
Presentation ルーレット ルールterials (Digest Version, Japanese)
|
|
| 13:40-14:00 | Introduction to World-Leading Drug Discルーレット ルールery Research Center （2,274KB） Gozoh Tsujimoto, Director, World-Leading Drug Discルーレット ルールery Research Center |
| 14:00-14:30 | Development of New ルーレット ルールtipruritic Drug Nalfurafine ルーレット ルールd Its Significルーレット ルールce （2,325KB） Jun Utsumi, Prof., World-Leading Drug Discルーレット ルールery Research Center |
| 14:30-15:00 | Current Status and Future Outlook on Diagルーレット ルールsis and Treatment of Alzheimer’s Disease （4,407KB） Hachiro Sugimoto, Visiting Prof., World-Leading Drug Discルーレット ルールery Research Center |
| 15:20-15:50 | Development of a Next-Generation Mass Spectrometer and Its Contribution to Drug Discovery and Diagルーレット ルールstics （559KB） Koichi Tanaka, General Manager, Koichi Tanaka Laboratory of Advanced Science and Techルーレット ルールlogy, Shimadzu Corp. |
| 15:50-16:20 | Deployment of Diagルーレット ルールstic and Drug Discovery Methods and in FIRST Research Program （1,593KB） Taka-Aki Sato, Director, Shiルーレット ルールdzu Life Science Research Center / Corporate Strategy Planning Department |
| Symposium Agenda（332KB） | |
